Search - tctmd.com

Displaying 21 - 36 of 36

Sort: Relevancy | Date

News Daily News

Women Treated for Acute HF Report Worse QoL Than Men

Caitlin E. Cox

March 12, 2021

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Daily News

Intensive BP Control Lengthens Life: SPRINT Analysis

Todd Neale

March 03, 2020

News Daily News

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Yael L. Maxwell

February 18, 2020

News Daily News

AHA/ACC Aim to Enhance Care of High BP With New Measures

Todd Neale

November 14, 2019

News Conference News SCAI 2019

New Cardiogenic Shock Definitions Create Common Lexicon for Healthcare Teams

Yael L. Maxwell

May 22, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Opinion Fellow Talk

Public Reporting and the Budding Interventional Cardiologist

Yashasvi Chugh, MD

March 28, 2019

News Opinion Fellow Talk

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

Yashasvi Chugh, MD

August 16, 2018

News Conference News ACC 2018

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Shelley Wood

March 27, 2018

News Daily News

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

L.A. McKeown

January 22, 2018

News Daily News

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

Todd Neale

December 04, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Yael L. Maxwell

August 03, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

Advertisement

Women Treated for Acute HF Report Worse QoL Than Men

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Intensive BP Control Lengthens Life: SPRINT Analysis

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

AHA/ACC Aim to Enhance Care of High BP With New Measures

New Cardiogenic Shock Definitions Create Common Lexicon for Healthcare Teams

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Public Reporting and the Budding Interventional Cardiologist

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

New Performance and Quality Metrics for STEMI and NSTEMI Care

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content